|
Class 1 Device Recall EZ Breathe Medication Cup |
|
Date Initiated by Firm |
April 30, 2013 |
Date Posted |
May 29, 2013 |
Recall Status1 |
Terminated 3 on June 28, 2016 |
Recall Number |
Z-1373-2013 |
Recall Event ID |
65070 |
Product Classification |
Nebulizer, medicinal, non-ventilatory (atomizer) - Product Code CCQ
|
Product |
EZ Breathe Medication Cup.
For the delivery of liquid medications for respiratory usage. |
Code Information |
Lots #120902, Lot # 120903 and Lot # 120904 |
Recalling Firm/ Manufacturer |
Nephron Pharmaceuticals Corp. 4121 SW 34th St Orlando FL 32811-6475
|
For Additional Information Contact |
Jerry Webb 800-443-4313 Ext. 2292
|
Manufacturer Reason for Recall |
Possible dislodgement of the "Plate A", if this instance occurs, it presents a potential choking hazard.
|
FDA Determined Cause 2 |
Nonconforming Material/Component |
Action |
The firm, Nephron Pharmaceuticals Corporation, notified its consignees on April 30, 2013, and May 3, 2013, of the problem via a recall notice and a Press Release, respectively. The firm directed consignees to discontinue use of any EZ Breathe atomizer units contained in the Asthmanefrin Starter Kits with the affected lot numbers and also those that were sold individually. Customers were directed to return all affected product. |
Quantity in Commerce |
750 Medications Cups |
Distribution |
Worldwide Distribution-USA (nationwide) including DC and Puerto Rico and the states of AL, AZ, CA, CO, CT, FL, IL, IN, IO, GA, KS, KY, LA, MD, MN, MS, MO, NK, NV, NJ, NM, NY, OH, OK, OR, PA, RI, SC, TN , TX, VT, VA, WA, and WV, and the countries of Guatemala, Poland, Panama, and United Kingdom. |
Total Product Life Cycle |
TPLC Device Report
|
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|
|
|
|